Polyomavirus BK in the pathogenesis of bladder cancer

Netherlands Journal of Medicine

Volumn 71, Issue 1, 2013, Pages 26-28

  van Aalderen, M C ^a   Yapici, U ^a   van der Pol, J A ^a   de Reijke, T M ^a   van Donselaar van der Pant, K A M I ^a   Florquin, S ^a   Bemelman, F J ^a   ten Berge, I J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bladder cancer; Kidney transplantation; Polyomavirus BK; Transforming viruses

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT;

ADULT; ARTERY THROMBOSIS; ARTICLE; BACTERIUM CULTURE; BK VIRUS; BK VIRUS INFECTION; BLADDER BIOPSY; BLADDER CANCER; CASE REPORT; CYSTOSCOPY; DEATH; DEEP VEIN THROMBOSIS; ECHOGRAPHY; ESCHERICHIA COLI; FEVER; HEMATURIA; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; IMMUNOSUPPRESSIVE TREATMENT; MALE; METASTASIS; MITOSIS; NEPHROSTOMY; PAIN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PYELOGRAPHY; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH; URETER OBSTRUCTION; VIRUS DETECTION; VIRUS LOAD;

BK VIRUS; CARCINOMA, TRANSITIONAL CELL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; URINARY BLADDER NEOPLASMS;

EID: 84874150945     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis. 1973;128:784-7.
2. van Aalderen MC, Heutinck KM, Huisman C, Ten Berge IJ. BK virus infection in transplant recipients: Clinical manifestations, treatment options and the immune response. Neth J Med. 2012;70:172-83.
3. Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant. 2010;10:2615-23.
4. Huang G, Chen LZ, Qiu J, et al. Prospective study of polyomavirus BK replication and nephropathy in renal transplant recipients in China: a single-center analysis of incidence, reduction in immunosuppression and clinical course. Clin Transplant. 2010;24:599-609.
5. Abend JR, Jiang M, Imperiale MJ. BK virus and human cancer: innocent until proven guilty. Semin Cancer Biol. 2009;19:252-60.
6. Dyson N, Bernards R, Friend SH, et al. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol. 1990;64:1353-6.
7. Lilyestrom W, Klein MG, Zhang R, Joachimiak A, Chen XS. Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. Genes Dev. 2006;20:2373-82.
8. Darbinyan A, Siddiqui KM, Slonina D, et al. Role of JC virus agnoprotein in DNA repair. J Virol. 2004;78:8593-600.
9. Monini P, Rotola A, Di Luca D, et al. DNA rearrangements impairing BK virus productive infection in urinary tract tumors. Virology. 1995;214:273-9.
10. Geetha D, Tong BC, Racusen L, Markowitz JS, Westra WH. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation. 2002;73:1933-6.
11. Galed-Placed I, Valbuena-Ruvira L. Decoy cells and malignant cells coexisting in the urine from a transplant recipient with BK virus nephropathy and bladder adenocarcinoma. Diagn Cytopathol. 2011;39:933-7.
12. Fioriti D, Pietropaolo V, Dal FS, Laurenti C, Chiarini F, Degener AM. Urothelial bladder carcinoma and viral infections: different association with human polyomaviruses and papillomaviruses. Int J Immunopathol Pharmacol. 2003;16:283-8.
13. Rollison DE, Sexton WJ, Rodriguez AR, Kang LC, Daniel R, Shah KV. Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder. Int J Cancer. 2007;120:1248-51.
14. Roberts IS, Besarani D, Mason P, Turner G, Friend PJ, Newton R. Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation. Br J Cancer. 2008;99:1383-6.
15. Weinreb DB, Desman GT, Amolat-Apiado MJ, Burstein DE, Godbold JH, Jr., Johnson EM. Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn Cytopathol. 2006;34:201-3.